---
title: "AmoyDx shareholder Xiamen Yixiang plans to reduce its holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238946458.md"
description: "According to the Zhitong Finance APP, AmoyDx announced that the company recently received a \"Reduction Plan Notification Letter\" issued by its shareholder Xiamen Yixiang Investment Partnership (Limited Partnership) (\"Xiamen Yixiang\"), intending to reduce its holdings by no more than 11.7918 million shares, which is no more than 3.00% of the company's total share capital"
datetime: "2025-05-06T14:43:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238946458.md)
  - [en](https://longbridge.com/en/news/238946458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238946458.md)
generator: "portal-rs"
---

# AmoyDx shareholder Xiamen Yixiang plans to reduce its holdings by no more than 3%

According to the announcement from Zhitong Finance APP, AmoyDx (300685.SZ) recently received a "Reduction Plan Notification Letter" issued by its shareholder Xiamen Yixiang Investment Partnership (Limited Partnership) ("Xiamen Yixiang"), intending to reduce its holdings by no more than 11.7918 million shares, which is no more than 3.00% of the company's total share capital

### Related Stocks

- [300685.CN](https://longbridge.com/en/quote/300685.CN.md)

## Related News & Research

- [Wetour Robotics Shareholders Approve Major Capital Restructuring at August EGM](https://longbridge.com/en/news/296929137.md)
- [Billionaire Stanley Druckenmiller Drops Sharp Take on Bonds](https://longbridge.com/en/news/296945329.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [12:30 ETAPLA HEALTH'S 42ND ANNUAL AIDS WALK LOS ANGELES RETURNS TO WEST HOLLYWOOD ON OCTOBER 18, 2026](https://longbridge.com/en/news/296940018.md)
- [Seres-backed Aiva reportedly explores joining CATL battery swap network](https://longbridge.com/en/news/296920871.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**